Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$222
New position
Shares Held
2
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#296
of 299 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Downshift Financial, LLC holds $6,093 across 9 Biotechnology names. RYTM ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6 | $2,980 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4 | $1,204 | |
| 3 | INSM |
INSMED Inc
|
7 | $746 | |
| 4 | INCY |
Incyte Corp
|
3 | $340 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
4 | $317 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
2 | $222 | |
| 7 | IRON |
Disc Medicine, Inc.
|
2 | $146 | |
| 8 | QURE |
uniQure N.V.
|
3 | $138 |
All Filings in RYTM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222 | 2 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||